|
Get Full Access To This Report | or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
Inclinix, Inc.
Business Summary
Inclinix, Inc. is a privately-held, venture capital backed clinical trial enrollment solutions company. Inclinix specializes in customized Phase I-IV clinical trial enrollment solutions for global pharmaceutical, biotechnology, and medical device organizations. Founded in 1999 by J. Tobin Geatz, Inclinix is headquartered in Wilmington, North Carolina.
Overview & Corporate Organization
Basic Information
| Company Tags: | PE Backed VC Backed |
| Year Founded: | 1999 |
| Formerly Named: | PharmaTech Solutions, Inc. |
| Fiscal Year End: | 12/31 |
| City: | Wilmington |
| State/Province: | North Carolina |
| Country: | United States |
| Phone: | View |
| Website: | www.inclinix.com |
Industry Information
PrivCo Industries (Sector > Industry > Sub-Industry)
| Healthcare > Clinical Research Services > Other Clinical Research Services |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Mergers & Acquisitions
| Date | Status | Target | Buyer | Deal Type | Price | |
| Details | Jun. 2012 | Completed | View | View | Acquisition | View |
Missing a deal? Tell us about it! tips@privco.com
VC/Funding Activity
| Date | Investor | Round | Investor Type | |
| Jan. 2008 | View | Other | Private Equity | |
| Details | Total Round Other View | |||
| Sep. 2010 | View | B | Private Equity | |
| Details | Total Round B View | |||
| Total of Funding Shown Above View | ||||
Missing a deal? Tell us about it! tips@privco.com
Supplemental Resources
|
Get Full Access To This Report | or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |




